Lifestyle Changes for Improving Disease-specific Quality of Life in Sedentary Men on Long-term Androgen-Deprivation Therapy for Advanced Prostate Cancer: A Randomised Controlled Trial. By Bourke et al. 2014

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial. By Denham et al. 2014

Functional and metabolic complications of androgen deprivation therapy. By Herrera-Caceres and Castillejos-Molina 2014 

Influence of Age on Incident Diabetes and Cardiovascular Disease Among Prostate Cancer Survivors Receiving Androgen Deprivation Therapy. By Morgans et al. 2014 

Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies. By Zhao et al. 2014 

Sexual Bother in Men with Advanced Prostate Cancer Undergoing Androgen Deprivation Therapy. By Benedict et al. 2014 

Positive and negative mood in men with advanced prostate cancer undergoing androgen deprivation therapy: considering the role of social support and stress. By Benedict et al. 2014 

Risk of New-onset Diabetes after Androgen Deprivation Therapy for Prostate Cancer in the Asian Population. By Teoh et al. 2014 

Muscle and bone effects of androgen deprivation therapy: current and emerging therapies. By Lee et al. 2014 

Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment. By Graham-Steed et al. 2014.

Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study. By Morgans et al. 2014.

Androgen-deprivation-associated bone disease. By Skolarus et al. 2014.

Adverse effects of androgen deprivation therapy in prostate cancer and their management. By Rhee et al. 2014